FSCN1 and non-small cell lung carcinoma: Kaplan-Meier survival analysis revealed that the expression levels of ANLN, BMP2, CALU, COL1A1, COL1A2, COL3A1, ERO1A, FSCN1, FZD3, LOXL2, MME, MSI2, NFIX, PTX3, RTKN2, SLC2A1, SLC16A1, and SNX30 were relevant with poor prognosis in NSCLC patients (Figure 7).